Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jerums

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Lancet (London, England)|October 21, 1995
Prevention of diabetic renal disease with special reference to microalbuminuriaC E Mogensen, W F Keane, P H Bennett, et al.
The Journal of Clinical Investigation|December 19, 2001
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)M D Oldfield, L A Bach, J M Forbes, et al.
Bone|May 8, 2012
Increased bone mineral density in Aboriginal and Torres Strait Islander Australians: impact of body composition differencesL J Maple-Brown, J Hughes, L S Piers, et al.
Diabetologia|June 6, 2006
Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methodsR J Macisaac, C Tsalamandris, M C Thomas, et al.
Kidney International|October 10, 1998
Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic ratsR E Gilbert, J L Wilkinson-Berka, D W Johnson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2007
The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetesR J Macisaac, C Tsalamandris, M C Thomas, et al.
Diabetologia|May 7, 1999
A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetesT Soulis, S Sastra, V Thallas, et al.
Diabetes|January 1, 2000
Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase CT M Osicka, Y Yu, S Panagiotopoulos, et al.
Nephrology (Carlton, Vic.)|December 19, 2017
Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR StudyJ T Hughes, L J Maple-Brown, M Thomas, et al.
Diabetologia|December 29, 2000
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetesR E Gilbert, D J Kelly, A J Cox, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Lancet (London, England)|October 21, 1995
Prevention of diabetic renal disease with special reference to microalbuminuriaC E Mogensen, W F Keane, P H Bennett, et al.
The Journal of Clinical Investigation|December 19, 2001
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE)M D Oldfield, L A Bach, J M Forbes, et al.
Bone|May 8, 2012
Increased bone mineral density in Aboriginal and Torres Strait Islander Australians: impact of body composition differencesL J Maple-Brown, J Hughes, L S Piers, et al.
Diabetologia|June 6, 2006
Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methodsR J Macisaac, C Tsalamandris, M C Thomas, et al.
Kidney International|October 10, 1998
Renal expression of transforming growth factor-beta inducible gene-h3 (beta ig-h3) in normal and diabetic ratsR E Gilbert, J L Wilkinson-Berka, D W Johnson, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|March 29, 2007
The accuracy of cystatin C and commonly used creatinine-based methods for detecting moderate and mild chronic kidney disease in diabetesR J Macisaac, C Tsalamandris, M C Thomas, et al.
Diabetologia|May 7, 1999
A novel inhibitor of advanced glycation end-product formation inhibits mesenteric vascular hypertrophy in experimental diabetesT Soulis, S Sastra, V Thallas, et al.
Diabetes|January 1, 2000
Prevention of albuminuria by aminoguanidine or ramipril in streptozotocin-induced diabetic rats is associated with the normalization of glomerular protein kinase CT M Osicka, Y Yu, S Panagiotopoulos, et al.
Nephrology (Carlton, Vic.)|December 19, 2017
Cross-sectional associations of albuminuria among Aboriginal and Torres Strait Islander adults: the eGFR StudyJ T Hughes, L J Maple-Brown, M Thomas, et al.
Diabetologia|December 29, 2000
Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetesR E Gilbert, D J Kelly, A J Cox, et al.
Pageof 16